glp-1 for crohn's The Potential GLP-1s in the Treatment of Disease ulcerative colitis glp 1 New
Description
It is FDA-approved for neuropathic pain and is considered a first-line treatment for allodynia
Patient characteristics affecting the tumor risk of GLP-1RAs Age and gender Meta-analyses have demonstrated that GLP-1RAs reduce the risk of prostate cancer, particularly in older male populations [115]
Alongside nausea, many people experience vomiting, diarrhea, constipation, and abdominal discomfort
Clin Res
2012;18:BR 286BR 291
Our health content is for informational purposes only and is not intended as professional medical advice
